US Capitol Capsule: FDA's CDER ends 2011 with 30 new drugs and biologics
03 January 2012
Donna Young
Please Login to read the full article.
03 January 2012
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- ODAC backs ApoPharma's iron chelator, but lacks harmony on prostate cancer trials
- FDA's Woodcock attributes 35 NME approvals to agency flexibility, creativity
- Iron chelator, prostate cancer conundrum on deck for ODAC
- Jazz' $700 million EUSA buy diversifies portfolio and broadens reach
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
